• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by Centene Corporation (Amendment)

    2/13/24 5:01:02 PM ET
    $CNC
    Medical Specialities
    Health Care
    Get the next $CNC alert in real time by email
    SC 13G/A 1 tv0565-centenecorp.htm SCHEDULE 13G/A centenecorp

    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    Schedule 13G

    Under the Securities Exchange Act of 1934
    (Amendment No.: 13)*

    Name of issuer:  Centene Corp

    Title of Class of Securities:  Common Stock

    CUSIP Number:  15135B101

    Date of Event Which Requires Filing of this Statement: December 29, 2023

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

    ☒ Rule 13d-1(b)

    ☐ Rule 13d-1(c)

    ☐ Rule 13d-1(d)

    *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

    The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

    (Continued on the following page(s))

     

     

    13G

    CUSIP No.:  15135B101

    1.  NAME OF REPORTING PERSON
    I.R.S. IDENTIFICATION NO. OF ABOVE PERSON

    The Vanguard Group - 23-1945930

    2.  CHECK THE APPROPRIATE [LINE] IF A MEMBER OF A GROUP

    A. 

    B.  X

    3.  SEC USE ONLY

    4.  CITIZENSHIP OF PLACE OF ORGANIZATION

    Pennsylvania

    (For questions 5-8, report the number of shares beneficially owned by each reporting person with:)

    5.  SOLE VOTING POWER

    0

    6.  SHARED VOTING POWER

    717,036

    7.  SOLE DISPOSITIVE POWER

    58,877,252

    8.  SHARED DISPOSITIVE POWER

    2,313,336

    9.  AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

    61,190,588

    10.  CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

    N/A

    11.  PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

    11.45%

    12.  TYPE OF REPORTING PERSON

    IA

     

     

    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    Schedule 13G
    Under the Securities Act of 1934

    Item 1(a) - Name of Issuer:

    Centene Corp

    Item 1(b) - Address of Issuer's Principal Executive Offices:

    7700 Forsyth Boulevard
    St. Louis, MO 63105

    Item 2(a) - Name of Person Filing:

    The Vanguard Group - 23-1945930

    Item 2(b) – Address of Principal Business Office or, if none, residence:

    100 Vanguard Blvd.
    Malvern, PA 19355

    Item 2(c) – Citizenship:

    Pennsylvania

    Item 2(d) - Title of Class of Securities:

    Common Stock

    Item 2(e) - CUSIP Number

    15135B101

    Item 3 - Type of Filing:

    This statement is being filed pursuant to Rule 13d-1.  An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E).

    Item 4 - Ownership:

      (a) Amount Beneficially Owned:

      (b) Percent of Class:

     

     

    (c)  Number of shares as to which such person has:

    (i)  sole power to vote or direct to vote:  

    (ii)  shared power to vote or direct to vote:  

    (iii)  sole power to dispose of or to direct the disposition of:  

    (iv)  shared power to dispose or to direct the disposition of:  

    Comments:

    The responses to questions 5 through 9 and 11 on the cover page(s) are incorporated by reference into this Item 4.  

    Item 5 - Ownership of Five Percent or Less of a Class:

    If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following ☐

    Item 6 - Ownership of More Than Five Percent on Behalf of Another Person:

    The Vanguard Group, Inc.'s clients, including investment companies registered under the Investment Company Act of 1940 and other managed accounts, have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the securities reported herein.

    No one other person's interest in the securities reported herein is more than 5%.

    Item 7 - Identification and Classification of the Subsidiary Which Acquired The Security Being Reported on by the Parent Holding Company:

    Not applicable

    Item 8 - Identification and Classification of Members of Group:

    Not applicable

    Item 9 - Notice of Dissolution of Group:

    Not applicable

    Item 10 - Certification:

    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under §240.14a-11.

    Signature

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

    Date:  February 13, 2024

    By /s/ Ashley Grim
    Name: Ashley Grim
    Title:  Head of Global Fund Administration

    Get the next $CNC alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CNC

    DatePrice TargetRatingAnalyst
    6/23/2026$70.00Sector Perform
    RBC Capital Mkts
    5/20/2026$80.00Hold → Buy
    Deutsche Bank
    4/29/2026$60.00Neutral → Overweight
    Cantor Fitzgerald
    4/29/2026$60.00Underperform → Buy
    BofA Securities
    1/5/2026$54.00Equal Weight → Overweight
    Barclays
    10/14/2025$33.00Sell
    Goldman
    7/28/2025$38.00Overweight → Neutral
    Cantor Fitzgerald
    7/23/2025$30.00Overweight → Equal Weight
    Wells Fargo
    More analyst ratings

    $CNC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Tyler Lauren M was granted 3,155 shares, increasing direct ownership by 5,172% to 3,216 units (SEC Form 4)

    4 - CENTENE CORP (0001071739) (Issuer)

    7/20/26 4:45:58 PM ET
    $CNC
    Medical Specialities
    Health Care

    Director Tyler Lauren M was granted 61 shares (SEC Form 4)

    4 - CENTENE CORP (0001071739) (Issuer)

    7/1/26 5:47:29 PM ET
    $CNC
    Medical Specialities
    Health Care

    Director Samuels Theodore R. Ii was granted 465 shares, increasing direct ownership by 2% to 25,213 units (SEC Form 4)

    4 - CENTENE CORP (0001071739) (Issuer)

    7/1/26 5:47:18 PM ET
    $CNC
    Medical Specialities
    Health Care

    $CNC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    RBC Capital Mkts initiated coverage on Centene with a new price target

    RBC Capital Mkts initiated coverage of Centene with a rating of Sector Perform and set a new price target of $70.00

    6/23/26 8:23:13 AM ET
    $CNC
    Medical Specialities
    Health Care

    Centene upgraded by Deutsche Bank with a new price target

    Deutsche Bank upgraded Centene from Hold to Buy and set a new price target of $80.00

    5/20/26 8:03:29 AM ET
    $CNC
    Medical Specialities
    Health Care

    Centene upgraded by Cantor Fitzgerald with a new price target

    Cantor Fitzgerald upgraded Centene from Neutral to Overweight and set a new price target of $60.00

    4/29/26 7:59:54 AM ET
    $CNC
    Medical Specialities
    Health Care

    $CNC
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    CENTENE CORPORATION TO HOST 2026 SECOND QUARTER FINANCIAL RESULTS EARNINGS CALL

    ST. LOUIS, July 10, 2026 /PRNewswire/ -- Centene Corporation (NYSE:CNC), a leading healthcare enterprise committed to helping people live healthier lives, shared today that it will release its 2026 second quarter financial results at approximately 6:00 a.m. ET on Tuesday, July 28, 2026, and host a conference call at 8:30 a.m. ET to review the results. Investors and other interested parties are invited to listen to the conference call by dialing 1-877-883-0383 (toll free) in the U.S. and Canada; +1-412-902-6506 (toll) from abroad, including the following Elite Entry Number: 4306002 to expedite caller registration; or via a live,

    7/10/26 8:45:00 AM ET
    $CNC
    Medical Specialities
    Health Care

    CENTENE SUBSIDIARY MERIDIAN HEALTH PLAN OF ILLINOIS AWARDED ILLINOIS MEDICAID CONTRACT

    ST. LOUIS, July 9, 2026 /PRNewswire/ -- Centene Corporation (Centene) (NYSE:CNC), a leading healthcare enterprise committed to helping people live healthier lives, announced today that its Illinois subsidiary, Meridian Health Plan of Illinois, Inc. (Meridian), has been selected by the Illinois Department of Healthcare and Family Services (HFS) to continue providing services for the HealthChoice Illinois Medicaid managed care program. The four-year contract is expected to begin January 1, 2027, through 2030. "Centene has a long track record serving Medicaid and dually eligible Medicaid-Medicare members in Illinois," said Chief E

    7/9/26 7:00:00 AM ET
    $CNC
    Medical Specialities
    Health Care

    Health Net Providing Special Assistance to Members and Providers Affected by Palos Warehouse Fire in Los Angeles

    SACRAMENTO, Calif., June 23, 2026 /PRNewswire/ -- Following Gov. Newsom's declaration of a State of Emergency in Los Angeles County, Health Net, one of California's most experienced Medi-Cal managed care health plans and company of Centene Corporation (NYSE:CNC), is taking immediate action to support those affected by the fire. The company's priority is ensuring both its members and healthcare providers have the resources they need during this critical time. Member Prescription InformationDuring a declared State of Emergency, impacted members have two options to secure an emergency supply of their medications:Members can fill t

    6/23/26 1:35:00 PM ET
    $CNC
    Medical Specialities
    Health Care

    $CNC
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Executive Officer London Sarah bought $490,365 worth of shares (19,230 units at $25.50), increasing direct ownership by 2% to 845,275 units (SEC Form 4)

    4 - CENTENE CORP (0001071739) (Issuer)

    8/11/25 5:28:22 PM ET
    $CNC
    Medical Specialities
    Health Care

    Director Samuels Theodore R. Ii bought $248,580 worth of shares (9,000 units at $27.62) (SEC Form 4)

    4 - CENTENE CORP (0001071739) (Issuer)

    7/29/25 6:01:58 PM ET
    $CNC
    Medical Specialities
    Health Care

    Director Greco Thomas bought $1,015,750 worth of shares (17,000 units at $59.75), increasing direct ownership by 736% to 19,309 units (SEC Form 4)

    4 - CENTENE CORP (0001071739) (Issuer)

    12/19/24 5:39:30 PM ET
    $CNC
    Medical Specialities
    Health Care

    $CNC
    SEC Filings

    View All

    Centene Corporation filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - CENTENE CORP (0001071739) (Filer)

    6/22/26 4:37:20 PM ET
    $CNC
    Medical Specialities
    Health Care

    Centene Corporation filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Leadership Update

    8-K - CENTENE CORP (0001071739) (Filer)

    5/15/26 4:06:58 PM ET
    $CNC
    Medical Specialities
    Health Care

    Centene Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - CENTENE CORP (0001071739) (Filer)

    4/27/26 8:08:15 PM ET
    $CNC
    Medical Specialities
    Health Care

    $CNC
    Financials

    Live finance-specific insights

    View All

    CENTENE CORPORATION TO HOST 2026 SECOND QUARTER FINANCIAL RESULTS EARNINGS CALL

    ST. LOUIS, July 10, 2026 /PRNewswire/ -- Centene Corporation (NYSE:CNC), a leading healthcare enterprise committed to helping people live healthier lives, shared today that it will release its 2026 second quarter financial results at approximately 6:00 a.m. ET on Tuesday, July 28, 2026, and host a conference call at 8:30 a.m. ET to review the results. Investors and other interested parties are invited to listen to the conference call by dialing 1-877-883-0383 (toll free) in the U.S. and Canada; +1-412-902-6506 (toll) from abroad, including the following Elite Entry Number: 4306002 to expedite caller registration; or via a live,

    7/10/26 8:45:00 AM ET
    $CNC
    Medical Specialities
    Health Care

    CENTENE CORPORATION TO HOST 2026 FIRST QUARTER FINANCIAL RESULTS EARNINGS CALL

    ST. LOUIS, April 10, 2026 /PRNewswire/ -- Centene Corporation (NYSE:CNC), a leading healthcare enterprise committed to helping people live healthier lives, shared today that it will release its 2026 first quarter financial results at approximately 6:00 a.m. ET on Tuesday, April 28, 2026, and host a conference call at 8:30 a.m. ET to review the results. Investors and other interested parties are invited to listen to the conference call by dialing 1-877-883-0383 (toll free) in the U.S. and Canada; +1-412-902-6506 (toll) from abroad, including the following Elite Entry Number: 0526

    4/10/26 9:48:00 AM ET
    $CNC
    Medical Specialities
    Health Care

    CENTENE CORPORATION REPORTS 2025 RESULTS AND ANNOUNCES 2026 GUIDANCE

    -- 2025 Full Year GAAP Diluted Loss Per Share of $(13.53); Adjusted Diluted Earnings Per Share of $2.08 -- -- 2026 Adjusted Diluted Earnings Per Share Guidance of Greater than $3.00 -- Consolidated HBR of 94.3% in the fourth quarter of 2025, which includes a Commercial HBR of 95.4% that was 100 basis points higher than expectations driven by net out of period items.Medicaid HBR of 93.0% in the fourth quarter of 2025, reflecting continued progress and representing 40 basis points of sequential improvement compared to the third quarter.Fundamental fourth quarter 2025 trend was consistent with expectations in Medicaid and Medicare Advantage, and slightly favorable in Marketplace and Medicare PD

    2/6/26 6:00:00 AM ET
    $CNC
    Medical Specialities
    Health Care

    $CNC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Centene Corporation

    SC 13G - CENTENE CORP (0001071739) (Subject)

    11/14/24 4:06:01 PM ET
    $CNC
    Medical Specialities
    Health Care

    Amendment: SEC Form SC 13G/A filed by Centene Corporation

    SC 13G/A - CENTENE CORP (0001071739) (Subject)

    11/13/24 3:02:23 PM ET
    $CNC
    Medical Specialities
    Health Care

    Amendment: SEC Form SC 13G/A filed by Centene Corporation

    SC 13G/A - CENTENE CORP (0001071739) (Subject)

    11/12/24 9:55:15 AM ET
    $CNC
    Medical Specialities
    Health Care

    $CNC
    Leadership Updates

    Live Leadership Updates

    View All

    CENTENE APPOINTS LAUREN M. TYLER TO BOARD OF DIRECTORS

    ST. LOUIS, June 22, 2026 /PRNewswire/ -- Centene Corporation (NYSE:CNC) today announced the appointment of Lauren M. Tyler to its Board of Directors, effective June 19, 2026. Ms. Tyler will serve on the Audit Committee and Compensation and Talent Committee. Ms. Tyler brings more than 30 years of leadership experience across investment banking, private equity, corporate audit, investor relations, and human capital strategy."Lauren's longstanding track record guiding global, complex organizations through transformation while prioritizing governance, talent development, and operati

    6/22/26 4:30:00 PM ET
    $CNC
    Medical Specialities
    Health Care

    Centene Announces New Executive Leadership Structure

    Appoints Daniel Finke to Group President, Markets and Commercial and Wellcare CEO Michael Carson to Group President, Medicare and Specialty  ST. LOUIS, April 6, 2026 /PRNewswire/ -- Centene Corporation (NYSE:CNC), a leading healthcare enterprise committed to helping people live healthier lives, today announced the creation of two new executive leadership positions, which will report to Chief Executive Officer Sarah London. Centene has hired Daniel Finke as Group President, Markets and Commercial, and appointed Michael Carson to Group President, Medicare and Specialty. "We are pl

    4/6/26 7:00:00 AM ET
    $CNC
    Medical Specialities
    Health Care

    eHealth Announces CEO Succession

    Derrick Duke Appointed Chief Executive Officer After Transition Period Fran Soistman to Retire, Remain on eHealth Board of Directors AUSTIN, Texas, July 29, 2025 /PRNewswire/ -- eHealth, Inc. (NASDAQ:EHTH), a leading private online health insurance marketplace (the "Company"), today announced that the Company's Board of Directors has appointed Derrick Duke as its next Chief Executive Officer. Duke will join eHealth on August 4th 2025, to begin the transition process before officially stepping into the CEO role and joining the Board of Directors on September 18th, 2025. He will succeed Fran Soistman, who, as previously announced, will retire from his role as CEO while continuing to serve on t

    7/29/25 9:00:00 AM ET
    $CNC
    $EHTH
    Medical Specialities
    Health Care
    Specialty Insurers
    Finance